Accessibility Menu
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft(OTC) SUVPF

Current Price$256.25
Market Cap$17.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+622%
5 Year-55%
1 Year-1%
1 Month+5%
Sartorius Aktiengesellschaft last closing stock price
MetricPriceDate
Last closeUSD 256.252026-07-21
Sartorius Aktiengesellschaft stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.1%USD 243.822026-06-18
1 month+5.1%USD 243.822026-06-18
3 month-8.91%USD 281.322026-04-20
Year to date-4.32%USD 267.832025-12-22
1 year-0.73%USD 258.142025-07-21
3 year-31.77%USD 375.592023-07-21
5 year-54.82%USD 567.232021-07-15
Since inception+622.28%USD 35.482008-03-05

Sartorius Aktiengesellschaft Financials at a Glance

Market Cap

$17.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.58B

Net Income (TTM)

€196.29M

EPS (TTM)

$3.31

P/E Ratio

77.36

Dividend

$0.85

Beta (Volatility)

0.24 (Low)

Price

$256.25

Volume

1

Open

$256.25

Previous Close

$256.25

Daily Range

$256.25 - $256.25

52-Week Range

$208.00 - $312.93

Estimated Earnings Date

Oct 22, 2026

SUVPF News

GettyImages-1134770722

With GE Deal Complete, Danaher Becomes The Leader in Bioprocessing

William AlderJan 29, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sartorius Aktiengesellschaft

Sartorius AG, established in 1870 and based in Göttingen, Germany, is a leading global supplier of innovative bioprocess solutions and laboratory products. The company supports life science research and biopharmaceutical manufacturing with a diverse portfolio of advanced tools and services.

Products and Services
  • Advanced analytics tools including biosensors and live-cell analysis platforms
  • Comprehensive cell culture and fermentation solutions with various bioreactors
  • Filtration and separation products for sterile processing and sample preparation
Growth Outlook
  • Strong demand in biopharmaceutical manufacturing drives revenue growth
  • Expansion into emerging markets enhances global reach and market share
  • Investment in R&D supports innovation and product development
Financial Highlights
  • Recent quarterly revenue of €902.5 million reflects a solid performance
  • Trailing twelve months (TTM) net income margin stands at 4.58%
  • Operating cash flow of €177.1 million indicates strong liquidity
Sartorius AG operates in the healthcare sector, focusing on medical instruments and supplies. The company has demonstrated resilience and adaptability in a competitive market, with a market capitalization of approximately $16.8 billion. Recent financial performance highlights include a revenue of €902.5 million for the first quarter of 2026, showcasing a robust demand for its products and services. The TTM net income margin of 4.58% reflects effective cost management and operational efficiency. Additionally, the operating cash flow of €177.1 million indicates a strong liquidity position, allowing for continued investment in growth initiatives. Sartorius AG's commitment to innovation and quality positions it well for future growth in the life sciences sector.
AI Generated • Jul 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

14,279

CEO

Michael Grosse, PhD

Website

www.sartorius.com

Headquarters

Göttingen, NI 37079, DE

SUVPF Financials

Key Financial Metrics (TTM)

Gross Margin

45.71%

Operating Margin

17.68%

Net Income Margin

4.79%

Return on Equity

6.28%

Return on Capital

9.32%

Return on Assets

1.79%

Earnings Yield

1.29%

Dividend Yield

0.33%

Payout Ratio

29.64%

Stock Overview

Market Cap

$17.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

69.05M

Volume

1

Avg. Volume

31.097

Financials (TTM)

Gross Profit

€1.64B

Operating Income

€633.82M

EBITDA

€1.04B

Operating Cash Flow

€735.09M

Capital Expenditure

-€442.24M

Free Cash Flow

€293.01M

Cash & ST Invst.

€306.90M

Total Debt

€4.05B

Sartorius Aktiengesellschaft Performance Analysis

Sartorius Aktiengesellschaft annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 4,387,502,4807.6%
20232023-12-31EUR 3,671,144,253-16.3%
20242024-12-31EUR 3,656,871,940-0.4%
20252025-12-31EUR 3,993,021,6479.2%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.5%
Q42025-12-319.8%
Q12026-03-31-2.7%
Q22026-06-300.9%
Sartorius Aktiengesellschaft annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 10.4289.1%
20232023-12-31EUR 3.25-68.8%
20242024-12-31EUR 1.32-59.5%
20252025-12-31EUR 2.5392.2%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3036.2%
Q42025-12-31-32.8%
Q12026-03-3190.7%
Q22026-06-3015.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€910.44M

+3.0%

Gross Profit

€432.45M

+3.9%

Gross Margin

47.50%

N/A

Market Cap

$17.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.30M

N/A

Employees

13,573

N/A

Net Income

€65.80M

+102.5%

EBITDA

€280.78M

+19.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€306.90M

-64.8%

Total Debt

€4.05B

-13.0%

Accounts Receivable

€305.90M

-2.4%

Inventory

€831.90M

+4.3%

Long Term Debt

€3.65B

-10.8%

Short Term Debt

€403.90M

-28.8%

Return on Assets

1.79%

N/A

Return on Invested Capital

7.76%

N/A

Free Cash Flow

€92.10M

+42.1%

Operating Cash Flow

€175.50M

+16.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SAUHYStraumann Holding AG
$11.64-1.02%
SDMHFSartorius Stedim Biotech S.A.
$193.00+0.52%
TRUMFTerumo Corporation
$12.76-8.86%
IVBXFInnovent Biologics, Inc.
$10.83-15.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About SUVPF

What is the current price of Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft is trading at $256.25 per share.

What is the 52-week range for Sartorius Aktiengesellschaft?

Over the past 52 weeks, Sartorius Aktiengesellschaft has traded between $208.00 and $312.93.

How much debt does Sartorius Aktiengesellschaft have?

As of the most recent reporting period, Sartorius Aktiengesellschaft reported total debt of €4.63B.

How much cash does Sartorius Aktiengesellschaft have on hand?

Sartorius Aktiengesellschaft reported €332.70M in cash and cash equivalents in its most recent financial results.

What is Sartorius Aktiengesellschaft’s dividend yield?

Sartorius Aktiengesellschaft currently has a dividend yield of 0.33%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services